Story perspectives

Genetic Analysis Market Poised for $10.29 Billion Surge

9/7/2025

Summary

Story summary

The genetic analysis market is set to grow from $9.09 billion in 2024 to $10.29 billion in 2025, fueled by increased cancer diagnoses and personalized medicine demand.
Somatic genetic testing is projected to rise from $6.81 billion in 2024 to $7.78 billion in 2025, emphasizing early disease detection and customized treatments.
Innovations like liquid biopsy tests improve diagnostic accuracy and minimize invasive procedures.
North America leads in genetic analysis and somatic testing, while Asia-Pacific is the fastest-growing region.
New solutions, such as Devyser LynchFAP and Devyser BRCA PALB2, enhance hereditary cancer detection and lab integration.

1 of 1

Story summary

The genetic analysis market is set to grow from $9.09 billion in 2024 to $10.29 billion in 2025, fueled by increased cancer diagnoses and personalized medicine demand.
Somatic genetic testing is projected to rise from $6.81 billion in 2024 to $7.78 billion in 2025, emphasizing early disease detection and customized treatments.
Innovations like liquid biopsy tests improve diagnostic accuracy and minimize invasive procedures.
North America leads in genetic analysis and somatic testing, while Asia-Pacific is the fastest-growing region.
New solutions, such as Devyser LynchFAP and Devyser BRCA PALB2, enhance hereditary cancer detection and lab integration.